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ABSTRACT
Intracoronary ECG, which was created with unipolar guide 
introduced into coronary artery to analyze ischemia, was 
invented in 1974, and firstly performed in human body in 
1985, Intracoronary ECG still remains rarely used technique for 
percutaneous coronary interventions (PCI). The article sums 
up studies dating from 1974 to 2016 which show that intra-
coronary ECG is useful for discovering the zones of ischemia, 
predicting myocardial necrosis, exploring vital myocardium, 
predicting myocardial recovery during primary PCI and finding 
new possibilities for the development of PCI. Intracoronary ECG 
is still very cheap and easily performed, even though it requires 
additional time and deserves much more interest among the 
staff incatheterization laboratories. 
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STRESZCZENIE
Wewnątrzwieńcowe EKG zarejestrowane za pomocą jednobie-
gunowego prowadnika wprowadzonego do tętnicy wieńcowej 
w celu oceny niedokrwienia zostało wynalezione w 1974 roku, 
a po raz pierwszy zostało wykonane u człowieka w 1985 roku. 
Wewnątrzwieńcowe EKG wciąż jest bardzo rzadko stosowa-
ną techniką diagnostyczną podczas przezskórnej interwen-
cji wieńcowej (PCI). Artykuł ten podsumowuje badania z  lat 
1974–2016, pokazując, że wewnątrzwieńcowe EKG może być 
przydatne w znalezieniu strefy niedokrwienia, przewidywaniu 
martwicy mięśnia sercowego, detekcji żywotnego miokardium, 
prognozowaniu zdrowienia mięśnia sercowego po pierwotnej 
PCI, jak również w poszukiwaniu nowych strategii podczas PCI. 
Nadal bardzo tanie i  łatwe do wykonania, mimo że wymaga 
dodatkowego czasu, to zasługuje na większe zainteresowanie 
pracujących w pracowniach hemodynamiki.
Słowa kluczowe: EKG wewnątrzwieńcowe
Kardiol. Inwazyjna 2016; 11 (6): 38–41
Intracoronary ECG in treating 
bifurcational lesions
Coronary bifurcation lesions remain a major thera-
peutic challenge with high early and late complica-
tion rates. It has been shown that angiographically 
high grade ostial side branch (SB) stenosis is not 
flow limiting and may not cause ischemia. Previous 
studies [1] with delayed gadolinium enhancement 
magnetic resonance imaging (DGE-MRI) before and 
after bifurcation PCI demonstrated that the occur-
rence of angiographic stenosis which is more than 
70% in diameter is associated with periprocedural 
myonecrosis in the region of SB. Moreover, the 
post-procedural myocardial injury after uncompli-
cated percutaneous coronary intervention (PCI) is 
not uncommon [2–4] with the frequency of 5% to 
30%. Although this is thought to have no clinical 
significance, clinical trials demonstrated the incre-
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aasing risk of adverse cardiac events among patients 
with periprocedural myonecrosis [5].
In the study the authors [6] performed intracoro-
nary ECG (icECG) guided PCI of bifurcation lesion. 
True bifurcations (001) were 55% and provisional 
stenting was the default strategy. A wire in the 
main branch and second wire in the side branch 
monitored intracoronary ECG. An icECG map of 
the main artery and its side branches was created 
before, during and after the procedure. Troponin 
I was measured before and after the intervention. 
Final and residual intracoronary ST elevation was 
found in only 14% of the main branch (MB) and in 
19% of the side branch, intracoronary ST elevation 
occurred in 17% of the both branches. In total, ST 
elevation is present in 36% of the main branch 
and 31% of the side branch. There was significant 
difference between groups and the linear increase 
of the postprocedural troponin concentration with 
icECG STE (troponin I concentrations: SB vs. MB vs. 
SB+MB STE — 0.61 ± 1.76 ng/ml vs. 1.73 ± 6.16 
ng/ml vs. 2.99 ± 7.88 ng/ml, overall P < 0.001) in 
SB, though MB in both branches.
There were several major findings in this study. 
Firstly, a modified method for icECG recording of 
epicardial electric potentials was introduced for 
ischemic zone detection at conclusion of PCI for 
coronary bifurcation lesions. This method provides 
a unique opportunity for determining areas of resi-
dual ischemia, which may be probable sources of 
postprocedural increase in troponin I concentration. 
Secondly, this is the first study which demonstrates 
that about one third of patients have ischemia in 
,at least, one distal location (MB, SB or both) after 
stenting of coronary bifurcation lesions as detected 
by means of icECG. This residual ischemia was 
found to be a sensitive and specific marker for 
postprocedural increase of troponin and for predic-
tion of troponin defined postprocedural myocar-
dial infarction according to the third definition of 
myocardial infarction. Thirdly, it was found that the 
increase of ischemic territory in bifurcation region 
(SB region — MB region — both distal regions) is 
linearly related with postprocedural troponin I con-
centration. The icECG recording provides a possible 
mechanism for postprocedural increase of the rate 
of enzyme in patients with icECG STE in distal 
MB only may be distal embolization from plaque 
components, while spasm or local thrombosis of 
microcirculation appeared to be possible reason for 
those with icECG changes in both zones (below the 
stent and distal MB). This is in the agreement with 
magnetic resonance studies which demonstrated 
late gadolinium enhancement zones in adjacent 
areas around the stent. One third of patients had 
ischemia in SB region at the end of coronary bifur-
cation interventional procedure, unrelated to extent 
of SB final stenosis. The SB ostial stenosis, after 
stenting, correlated significantly with maximum 
icECG STE in SB region immediately after stenting, 
but not with final icECG STE in SB region. Although 
this parameter, as well as final SB ostial stenosis, 
did not correlate with either final icECG STE or 
postprocedural troponin elevation, almost 60% of 
patients had icECG STE after stenting in SB region 
(nearly half of this ischemia could be eliminated by 
balloon inflation at SB ostium). When attempted, 
balloon inflation at SB ostium was successful to 
eliminate ischemia and to prevent from further 
myonecrosis in almost 70% of cases. In cases whe-
re SB ostium ballooning is ineffective to alleviate 
SB ischemia (even after larger balloon dilatation), 
application of IIB/IIIA inhibitors and vasodialtors 
may be effective but the hypothesis remains to be 
validated. In cases where there was no icECG STE 
after stenting in SB region, no further treatment of 
SBes was needed regardless of the angiographic 
appearance of the lesion.
By using the icECG mapping technique, it was able 
to predict almost 80% of cases with any troponin 
I rise after intervention for coronary bifurcation ste-
nosis and 90% of troponin I rise more than 5 times 
the upper normal limit, with 95% negative predic-
tive value (i.e., the lack of icECG STE casuses 95% 
probability of negative troponin I after intervention). 
As a posthoc analysis occured, the residual ischemia 
in MB (ST segment change) was also significantly 
related with TLR (ST segment change (+) 14.2% 
vs. ST segment change (–) 3.6%, P = 0.031) but 
not in SB region [7]. Final residual ST elevation in 
the main branch is independent predictor for TLR 
for the following 12 months (OR = 5.3.19, CI = 
1.197–23.809, P = 0.028) [8].
Another important conclusion is that the final resi-
dual ST elevation in side branch is not depended 
on the final side branch stenosis > 50% as well as 
side branch stenosis > 50% which does not mean 
indicate that the stenosis is hemodynamically signi-
ficant when measured with FFR.
This statement is used in another study, comparing 
FFR result and intracoronary ECG in side branch after 
stenting the main branch. After stenting the main 
branch, there is often > 50% stenosis in the side 
branch, but it is rarely hemodynamically significant 
(FFR < 0.8), as well as there is rarely residual ST 
elevation in this side branch. If there is ST elevation 
on intracoronary ECG this could be hemodynamically 
significant stenosis acutely compromising SB ostium 
and this should be treated or distal embolization — 
SB may not have > 50% stenosis and usually FFR 
result is > 0.8.
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postconditioning
It is believed that recurrent ischemic episodes fail 
to deplete ATP in vitro [9, 10]. Recurrent angina is 
found to have benefit in infarct size [11]. This concept 
of ischemic preconditioning was tested through 
angioplasty using chest pain and measuring surface 
ECG, lactate levels as ischemic detectors [12]. Since 
intracoronary ECG is proven to be more sensitive 
than surface ECG in detecting ischemia it is better 
to be used in this setting. A study using consecutive 
balloon inflations showed that intracoronary ECG 
could show preconditioning [13]. Many studies 
[14–19] have used intracoronary ECG to search 
for substances that change preconditioning. The 
substances which attenuate preconditioning are 
found to be endothelin, phentolamine, bamiphy-
lline, aminophylline, enaprilat, dipyridamole and 
naloxone. Other substances as nitrates, adenosine, 
diltiazem, nifedipine and bradykinin showed to have 
preconditioning effects [20–25]. Some conditions 
like diabetes and increased age were proven to be 
not deleterious in preconditioning [26, 27].
On the contrary, postconditioning is a state in which 
induced ischemia provides protection to myocar-
dium against reperfusion damage. This was proved 
by two studies [28, 29] by measuring cardiac en-
zymes, cardiac function by echocardiography and 
measuring infarct size by 201thallium single photon 
emission computed tomography. They used surface 
ECG as a detector of ischemia and postconditioning. 
It would be interesting if intracoronary ECG was used 
and there would be differences in other endpoints. 
Limitations of the intracoronary ECG
There are basically two main limitations: 1) gaining 
good ECG trace which is operator dependent and 2) 
time needed to connect the PCI wire with unipolar 
lead, done with sterile crocodile wire clips. 
Sometimes when there is more than one wire, when 
stented region is long and there is too many “metal” 
or the connection between the wire and the unipolar 
lead is poor the ECG trace is not satisfactory. This 
problem can be tackled with adding an isolator for 
the guide wire like microcatheter or balloon catheter. 
Other important thing is that the wire tip is required 
to be largely straight, the tip must not be in more 
than 90° J-configuration and the tip of the wire must 
move freely. If the tip of the wire is wedged, the lesion 
current will appear from wire tip, which erroneously 
will be interpreted as ischemic changes. Hence, the 
operator must turn the wire clockwise-countercloc-
kwise to be sure that the tip is freely moving. 
Conclusion
Intracoronary ECG is easy to be performed once 
you have the tools which are not expensive. It is 
performed better in detecting ischemia and it finds 
its location easier than surface ECG, which is proved 
in many applications. It is expected that coronary 
intervention will be fast and exact and that adding 
a new method will inevitably slow down the interven-
tion. Sometimes the quality of the tracing is not 
good enough but could be modified at the expense 
of time and adding isolators that is why sterile con-
nectors are needed. This could help making better 
decisions about treating the target vessel and adding 
information in real time about myocardial damage. 
In bifurcational lesions intracoronary ECG shows the 
region of ischemia and it helps to decide whether to 
treat the side branch which could save procedural 
time and reduce the adverse events. 
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